JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, Y.
Right arrow Articles by Sukamoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, Y.
Right arrow Articles by Sukamoto, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HALOPERIDOL
*N,N'-BIS(2-METHYLPHENYL)GUANIDINE

Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3- di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa

Y Harada, H Hara and T Sukamoto

Department of Pharmacology, Kanebo, Ltd., Osaka, Japan.

We have identified and characterized sigma receptor sites in porcine gastric fundic mucosa by receptor binding assay techniques using two highly selective radioligands of sigma receptor, (+)-[3H]N- allylnormetazocine (SKF 10,047) and [3H]1,3-di(2-tolyl)guanidine (DTG). Specific binding of (+)-[3H]SKF 10,047 and [3H]DTG in porcine gastric fundic mucosa were saturable, reversible and of high affinity and capacity with Kd: 90.5 nM, Bmax: 1058 fmol/mg of protein and Kd: 53.6 nM, Bmax: 3573.3 fmol/mg of protein, respectively. The inhibitory effects of sigma receptor ligands on specific (+)-[3H]SKF 10,047 binding decreased in the following order: haloperidol > DTG > or = (+)- 3-(3-hydroxyphenol)-N- (1-propyl)piperidine (3-PPP) > (+)-SKF 10,047 > (-)-3-PPP > or = dextromethorphan > rimcazole > (-)-SKF 10,047. Specific (+)-[3H]SKF 10,047 binding sites showed stereoselectivity for stereoisomers of SKF 10,047 and 3-PPP and were highly correlated with the profile of sigma-1 sites. On the other hand, the inhibitory effects on specific [3H]DTG binding decreased in the following order: DTG > haloperidol > rimcazole > (+)-3-PPP > or = (-)-3-PPP > dextromethorphan > (+)-SKF 10,047 = (-)-SKF 10,047. Specific [3H]DTG binding sites did not show stereoselectivity and were highly correlated with the profile of sigma-2 sites. These findings indicate that porcine gastric fundic mucosa contains sigma receptor sites with the characteristic of sigma-1 sites and sigma-like sites showing several of the characteristics of sigma-2 sites (putative sigma-2 sites).

Volume 269, Issue 3, pp. 905-910, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. J. Molderings, K. Donecker, M. Burian, W. A. Simon, D. W. Schröder, and M. Göthert
Characterization of I2 Imidazoline and sigma  Binding Sites in the Rat and Human Stomach
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 170 - 177.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.